Osman Dar

Osman Dar

Auto-generated profile, based on publicly available information

Osman Dar

Affiliation Global Public Health Directorate, United Kingdom Health Security Agency, London, United Kingdom

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
EPEskild Petersen
Eskild Petersen
IAIbrahim Abubakar
Ibrahim Abubakar
CIChikwe Ihekweazu
Chikwe Ihekweazu
DHDavid Heymann
David Heymann
FNFrancine Ntoumi
Francine Ntoumi
AZAlimuddin Zumla
Alimuddin Zumla
The identification of monkeypox in 3 separate patients in the United Kingdom in September raised media and political attention on an emerging public health threat. Nigeria, whose last confirmed case of monkeypox was in 1978, is currently experiencing an unusually large and outbreak of human monkeypox cases, a 'One Human-Environmental-Animal Health' approach is being effectively used to define and tackle the outbreak. As of 13th October 2018, there have been one hundred and sixteen confirmed cases the majority of whom are under 40 years. Over the past 20 years ten Central and West African countries have reported monkeypox cases which have risen exponentially. We review the history and evolution of monkeypox outbreaks in Africa and USA, the changing clinical presentations, and discuss possible factors underlying the increasing numbers being detected including the cessation of smallpox vaccination programs. Major knowledge gaps remain on the epidemiology, host reservoir, and emergence, transmission, pathogenesis and prevention of monkeypoz.

1 April 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
NKNathan Kapata
Nathan Kapata
CIChikwe Ihekweazu
Chikwe Ihekweazu
FNFrancine Ntoumi
Francine Ntoumi
TRTajudeen Raji
Tajudeen Raji
PCPascalina Chanda-Kapata
Pascalina Chanda-Kapata
AZAlimuddin Zumla
Alimuddin Zumla

1 January 2016 in The Lancet
Verified
Journal Article
Open access
ODOsman A Dar
Osman A Dar
RHRumina Hasan
Rumina Hasan
JSJørgen Schlundt
Jørgen Schlundt
SHStephan Harbarth
Stephan Harbarth
GCGrazia Caleo
Grazia Caleo
DHDavid L Heymann
David L Heymann
The effectiveness of existing policies to control antimicrobial resistance is not yet fully understood. A strengthened evidence base is needed to inform effective policy interventions across countries with different income levels and the human health and animal sectors. We examine three policy domains-responsible use, surveillance, and infection prevention and control-and consider which will be the most effective at national and regional levels. Many complexities exist in the implementation of such policies across sectors and in varying political and regulatory environments. Therefore, we make recommendations for policy action, calling for comprehensive policy assessments, using standardised frameworks, of cost-effectiveness and generalisability. Such assessments are especially important in low-income and middle-income countries, and in the animal and environmental sectors. We also advocate a One Health approach that will enable the development of sensitive policies, accommodating the needs of each sector involved, and addressing concerns of specific countries and regions.

2 July 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
EPE Petersen
E Petersen
AZAlimuddin Zumla
Alimuddin Zumla
DHDs Hui
Ds Hui
LBL Blumberg
L Blumberg
Sofia R. ValdoleirosSofia R. Valdoleiros
Sofia R. Valdoleiros
MKMpg Koopmans
Mpg Koopmans

1 August 2018 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
AAAula Abbara
Aula Abbara
TRTimothy Rawson
Timothy Rawson
NKNabil Karah
Nabil Karah
WEWael Faroug Elamin
Wael Faroug Elamin
JHJames Hatcher
James Hatcher
ASAnnie Sparrow
Annie Sparrow
Current evidence describing antimicrobial resistance (AMR) in the context of the Syrian conflict is of poor quality and sparse in nature. This paper explores and reports the major drivers of AMR that were present in Syria pre-conflict and those that have emerged since its onset in March 2011. Drivers that existed before the conflict included a lack of enforcement of existing legislation to regulate over-the-counter antibiotics and notification of communicable diseases. This contributed to a number of drivers of AMR after the onset of conflict, and these were also compounded by the exodus of trained staff, the increase in overcrowding and unsanitary conditions, the increase in injuries, and economic sanctions limiting the availability of required laboratory medical materials and equipment. Addressing AMR in this context requires pragmatic, multifaceted action at the local, regional, and international levels to detect and manage potentially high rates of multidrug-resistant infections. Priorities are (1) the development of a competent surveillance system for hospital-acquired infections, (2) antimicrobial stewardship, and (3) the creation of cost-effective and implementable infection control policies. However, it is only by addressing the conflict and immediate cessation of the targeting of health facilities that the rehabilitation of the health system, which is key to addressing AMR in this context, can progress.

1 August 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Open access
MKMishal S Khan
Mishal S Khan
AOAnna Osei-Kofi
Anna Osei-Kofi
AOAbbas Omar
Abbas Omar
HKHilary Kirkbride
Hilary Kirkbride
AKAnthony Kessel
Anthony Kessel
ODOsman Dar
Osman Dar
Involuntary migration is a crucially important global challenge from an economic, social, and public health perspective. The number of displaced people reached an unprecedented level in 2015, at a total of 60 million worldwide, with more than 1 million crossing into Europe in the past year alone. Migrants and refugees are often perceived to carry a higher load of infectious diseases, despite no systematic association. We propose three important contributions that the global health community can make to help address infectious disease risks and global health inequalities worldwide, with a particular focus on the refugee crisis in Europe. First, policy decisions should be based on a sound evidence base regarding health risks and burdens to health systems, rather than prejudice or unfounded fears. Second, for incoming refugees, we must focus on building inclusive, cost-effective health services to promote collective health security. Finally, alongside protracted conflicts, widening of health and socioeconomic inequalities between high-income and lower-income countries should be acknowledged as major drivers for the global refugee crisis, and fully considered in planning long-term solutions.